Cargando…
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD – The ABACOPD Study
BACKGROUND: Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community. Acute exacerbations of COPD (AE-COPD) often result in administration of antibiotics although more than half of exacerbations are associated with detection of respiratory viruses...
Autores principales: | Rohde, Gernot G U, Koch, Armin, Welte, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350292/ https://www.ncbi.nlm.nih.gov/pubmed/25623589 http://dx.doi.org/10.1186/1471-2466-15-5 |
Ejemplares similares
-
Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study
por: Fukuchi, Yoshinosuke, et al.
Publicado: (2016) -
Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017) -
Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal
por: Grünewaldt, Achim, et al.
Publicado: (2022) -
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial
por: Worth, Heinrich, et al.
Publicado: (2009) -
Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)